Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve inter-alia, the Un-audited Financial Results of the Company for the half year ended September 30, 2026.

Ganga Pharmaceuticals Limited CIN: L99999MH1989PLC053392 Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305 Phone: 9834613142 |Website: www.ayurvedganga.com. | Email: ayurvedganga@gmail.com. October 27, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400 001 Scrip Code: 539680 Sub: Intimation of the Board Meeting Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please take note that a Meeting of the Board of Directors of the Company will be held on November 02, 2026 to consider and approve, inter-alia, the Un-audited Financial Results of the Company for the half year ended September 30, 2026. Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Company's Securities is already closed from October 01, 2026, for all Designated Persons of the Company and will open 48 hours after the aforesaid Audited Financial Results are declared to the Stock Exchange. Kindly take the same on records. Thanking You, Yours faithfully, For Ganga Pharmaceuticals Limited Bharat Sharma Managing Director DIN: 00077026 Email Id: bharat.sharma@gangapharma.in